CANCER 2026 , ,
Presentations this author is a contributor to:
Integrating venetoclax sensitivity profiling and high-throughput drug screening to inform personalised therapy in paediatric acute myeloid leukaemia (133063)
1:00 PM
Mehrin Zaman
Session 4: Molecular drivers of hematopoietic malignancies
Deciphering Mitotic and DNA Damage Pathways Driving Malignant Rhabdoid Tumour: Preclinical and Mechanistic Evaluation of Alisertib, Temozolomide, and Irinotecan Combination Therapy (#141)
5:40 PM
Kimberly Dias
Welcome Reception & Poster Session 1